{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:44Z","timestamp":1773878444484,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/J012149\/1"],"award-info":[{"award-number":["MR\/J012149\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King&apos;s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CS-11-001"],"award-info":[{"award-number":["CS-11-001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pscychresns.2025.112095","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:41:44Z","timestamp":1764088904000},"page":"112095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis"],"prefix":"10.1016","volume":"355","author":[{"given":"Yiling","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-8643","authenticated-orcid":false,"given":"Cathy","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-5091","authenticated-orcid":false,"given":"Elizabeth","family":"Appiah-Kusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lythgoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Modinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0436-8971","authenticated-orcid":false,"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pscychresns.2025.112095_bib0001","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuron.2018.09.029","article-title":"Somatostatin interneurons facilitate hippocampal-prefrontal synchrony and prefrontal spatial encoding","volume":"100","author":"Abbas","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pscychresns.2025.112095_bib0002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/appi.ajp.2015.15040485","article-title":"Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis","volume":"173","author":"Allen","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"13","key":"10.1016\/j.pscychresns.2025.112095_bib0003","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/j.neuropsychologia.2007.06.015","article-title":"Left ventrolateral prefrontal cortex and the cognitive control of memory","volume":"45","author":"Badre","year":"2007","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0004","series-title":"Effects of Cannabidiol On Symptoms In People At Clinical High Risk For Psychosis","author":"Bhattacharyya","year":"2024"},{"issue":"4","key":"10.1016\/j.pscychresns.2025.112095_bib0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by \u03b49-tetrahydrocannabinol: a neural basis for the effects of cannabis sativa on learning and psychosis","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0006","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pscychresns.2025.112095_bib0007","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","article-title":"Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial","volume":"75","author":"Bhattacharyya","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0008","first-page":"280","article-title":"Prefrontal cortex and long-term memory encoding: an integrative review of findings from neuropsychology and neuroimaging","volume":"13","author":"Blumenfeld","year":"2007","journal-title":"Neurosci.: Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2020.06.027","article-title":"Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Na\u00efve Patients With Schizophrenia or Psychosis","volume":"89","author":"Bojesen","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.pscychresns.2025.112095_bib0009","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1017\/S0033291723000144","article-title":"Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-na\u00efve patients with psychosis","volume":"53","author":"Bojesen","year":"2023","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.pscychresns.2025.112095_bib0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0730-725X(97)00135-5","article-title":"Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach","volume":"15","author":"Brammer","year":"1997","journal-title":"Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.pscychresns.2025.112095_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mrm.1910350219","article-title":"Statistical methods of estimation and inference for functional MR image analysis","volume":"35","author":"Bullmore","year":"1996","journal-title":"Magn. Reson. Med."},{"issue":"2","key":"10.1016\/j.pscychresns.2025.112095_bib0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W","article-title":"Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains","volume":"12","author":"Bullmore","year":"2001","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.0.CO;2-Q","article-title":"Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI","volume":"7","author":"Bullmore","year":"1999","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1109\/42.750253","article-title":"Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain","volume":"18","author":"Bullmore","year":"1999","journal-title":"IEEE Trans. Med. Imaging"},{"issue":"8","key":"10.1016\/j.pscychresns.2025.112095_bib0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jamapsychiatry.2021.1290","article-title":"Neurocognitive functioning in individuals at clinical high risk for psychosis: a systematic review and meta-analysis","volume":"78","author":"Catalan","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.pscychresns.2025.112095_bib0016","article-title":"Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia","volume":"32","author":"Daniel","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pscychresns.2025.112095_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/2045125319881916","article-title":"Cannabidiol as a potential treatment for psychosis","author":"Davies","year":"2019","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgad022","article-title":"Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk","volume":"4","author":"Davies","year":"2023","journal-title":"Schizophr. Bull. Open"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0019","first-page":"1","article-title":"Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol","author":"Davies","year":"2023","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.pscychresns.2025.112095_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: A network meta-analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry: Off. J. World Psychiatr. Assoc. (WPA)"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0021","doi-asserted-by":"crossref","unstructured":"Davies, C., Radua, J., Cipriani, A., Stahl, D., Provenzani, U., McGuire, P., & Fusar-Poli, P. (2018a). Frontiers | Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis. https:\/\/doi.org\/10.3389\/fpsyt.2018.00187.","DOI":"10.3389\/fpsyt.2018.00187"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0022","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r12053","article-title":"Interventions and transition in youth at risk of psychosis: a systematic review and meta-analyses","volume":"81","author":"Devoe","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.pscychresns.2025.112095_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.20220676","article-title":"The Nature of prefrontal cortical GABA neuron alterations in schizophrenia: markedly lower somatostatin and parvalbumin gene expression without missing neurons","volume":"180","author":"Dienel","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0024","unstructured":"Edgington, E., Edgington, E., & Onghena, P. (1995). Randomization Tests."},{"issue":"2","key":"10.1016\/j.pscychresns.2025.112095_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","article-title":"Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort","volume":"74","author":"Egerton","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pscychresns.2025.112095_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2014.143","article-title":"Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis","volume":"39","author":"Egerton","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0027","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1053-8119(03)00077-6","article-title":"Adaptive analysis of fMRI data","volume":"19","author":"Friman","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0028","doi-asserted-by":"crossref","unstructured":"Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J.I., & Radua, J. (2019). Frontiers | Preventive treatments for psychosis: umbrella review (Just the Evidence). https:\/\/doi.org\/10.3389\/fpsyt.2019.00764.","DOI":"10.3389\/fpsyt.2019.00764"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/schbul\/sbx199","article-title":"The circuitry of dopamine system regulation and its disruption in schizophrenia: insights into treatment and prevention","volume":"45","author":"Grace","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.pscychresns.2025.112095_bib0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2011.20","article-title":"Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study","volume":"16","author":"Howes","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pscychresns.2025.112095_bib0031","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.schres.2012.06.039","article-title":"Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging","volume":"140","author":"Hutcheson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.pscychresns.2025.112095_bib0032","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0896-6273(00)80474-2","article-title":"Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding","volume":"20","author":"Kelley","year":"1998","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pscychresns.2025.112095_bib0033","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jamapsychiatry.2013.2437","article-title":"Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia","volume":"70","author":"Kraguljac","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.614811","article-title":"Cannabidiol and amisulpride improve cognition in acute schizophrenia in an explorative, double-blind, active-controlled, randomized clinical trial","volume":"12","author":"Leweke","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pscychresns.2025.112095_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0074-7742(06)78004-7","article-title":"Deciphering the disease process of schizophrenia: The contribution of cortical GABA neurons","volume":"78","author":"Lewis","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"8","key":"10.1016\/j.pscychresns.2025.112095_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2017.249","article-title":"Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention","volume":"23","author":"Lieberman","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"32","key":"10.1016\/j.pscychresns.2025.112095_bib0037","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"13","key":"10.1016\/j.pscychresns.2025.112095_bib58","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1038\/s41386-017-0004-6","article-title":"Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis","volume":"43","author":"Modinos","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0039","first-page":"1","article-title":"A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-na\u00efve first episode psychosis patients","author":"Nelson","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib63","first-page":"108","article-title":"Hippocampal Dysconnectivity and Altered Glutamatergic Modulation of the Default Mode Network: A Combined Resting-State Connectivity and Magnetic Resonance Spectroscopy Study in Schizophrenia","volume":"7","author":"Nelson","year":"2022","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"issue":"7","key":"10.1016\/j.pscychresns.2025.112095_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/02698811211001107","article-title":"Cannabidiol modulation of hippocampal glutamate in early psychosis","volume":"35","author":"O\u2019Neill","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pscychresns.2025.112095_bib0041","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S0033291719003519","article-title":"Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis","volume":"51","author":"O\u2019Neill","year":"2021","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.pscychresns.2025.112095_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-019-0333-8","article-title":"Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder","volume":"44","author":"Pretzsch","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pscychresns.2025.112095_bib0043","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"issue":"9","key":"10.1016\/j.pscychresns.2025.112095_bib0044","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamapsychiatry.2021.0830","article-title":"Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis","volume":"78","author":"Salazar de Pablo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/schbul\/sbad123","article-title":"Prefrontal and hippocampal parvalbumin interneurons in animal models for schizophrenia: a systematic review and meta-analysis","volume":"50","author":"Santos-Silva","year":"2024","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0046","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.pscychresns.2025.112095_bib0047","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archgenpsychiatry.2009.115","article-title":"Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders","volume":"66","author":"Schobel","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0048","article-title":"A single dose of cannabidiol modulates the coupling between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis","author":"Shi","year":"2024","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.pscychresns.2025.112095_bib0049","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn1178","article-title":"Prefrontal and medial temporal lobe interactions in long-term memory","volume":"4","author":"Simons","year":"2003","journal-title":"Nat. Rev., Neurosci."},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41386-021-01089-0","article-title":"Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia","volume":"47","author":"Smucny","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2025.112095_bib0051","unstructured":"Spielberger, C.D., Gonzalez-Reigosa, F., & A.Martinez-Urrutia. (1971). Development of the Spanish edition of the state-trait anxiety inventory."},{"issue":"3","key":"10.1016\/j.pscychresns.2025.112095_bib0052","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pscychresns.2015.03.007","article-title":"Increased hippocampal blood volume and normal blood flow in schizophrenia","volume":"232","author":"Talati","year":"2015","journal-title":"Psychiatry Res.: Neuroimaging"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0053","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroimage.2006.11.054","article-title":"Analysis of a large fMRI cohort: statistical and methodological issues for group analyses","volume":"35","author":"Thirion","year":"2007","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2010.08.033","article-title":"Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis","volume":"69","author":"Valli","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pscychresns.2025.112095_bib59","first-page":"569","article-title":"Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition","volume":"5","author":"Wenneberg","year":"2020","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"issue":"1","key":"10.1016\/j.pscychresns.2025.112095_bib0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41398-019-0534-2","article-title":"Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis","volume":"9","author":"Wilson","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"11\u201312","key":"10.1016\/j.pscychresns.2025.112095_bib0056","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","article-title":"Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states","volume":"39","author":"Yung","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492725001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492725001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:23:24Z","timestamp":1773854604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492725001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S0925492725001507"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2025.112095","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2025.112095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112095"}}